Earnings Feed
Start Free
Home/Insiders/Longsworth Todd Christopher
LT
SEC Insider//CIK 0001693530

Longsworth Todd Christopher

CIK 00016935301 companyMALVERN, PA
SEC Profile

Transactions

50

Companies

1

Filings

8

CIK

0001693530

Recent Transactions

50 trades
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-08$70.10/sh−2,339→ 62,462 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-04$70.41/sh−1,973→ 64,801 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2022-03-03$74.50/sh−1,094→ 66,774 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2022-03-03$80.59/sh+6,106→ 6,106 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-07-06$137.12/sh+154→ 67,868 total
  • Sale
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-03-08$130.81/sh−2,404→ 67,714 total
  • Sale
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-03-04$137.55/sh−3,084→ 70,118 total
  • Award
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-03-02+10,342→ 73,202 total
  • Sale
    NovoCure Ltd$NVCR

    Restricted Share Units

    2021-03-02$152.05/sh−2,355→ 62,860 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2021-03-02+19,004→ 19,004 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-02-27$149.10/sh+5,555→ 65,215 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Restricted Stock Units

    2021-02-27−5,555→ 0 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$174.06/sh−2,502→ 67,201 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$176.22/sh−400→ 64,601 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$169.93/sh−2,542→ 88,214 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$173.88/sh−1,600→ 102,256 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$179.37/sh−900→ 96,056 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$14.37/sh+36,396→ 123,474 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$178.50/sh−900→ 60,860 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$177.31/sh−2,200→ 97,956 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$179.30/sh−1,200→ 59,660 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$169.19/sh−1,800→ 90,756 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$171.86/sh−10,110→ 105,156 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$168.80/sh−800→ 120,175 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$171.32/sh−4,826→ 83,388 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$175.28/sh−2,200→ 65,001 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2021-01-15−36,396→ 0 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$177.33/sh−2,841→ 61,760 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$167.76/sh−2,499→ 120,975 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$167.77/sh−3,500→ 92,556 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$175.14/sh−1,700→ 100,556 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$172.95/sh−1,300→ 103,856 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$173.10/sh−1,700→ 69,703 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$171.90/sh−11,985→ 71,403 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$178.68/sh−1,000→ 96,956 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$175.98/sh−400→ 100,156 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$171.18/sh−2,761→ 115,266 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2021-01-15$169.76/sh−2,148→ 118,027 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-07$50.41/sh+325→ 87,078 total
  • Sale
    NovoCure Ltd$NVCR

    Restricted Share Units

    2020-03-06$69.53/sh−2,499→ 86,753 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2020-03-03+37,058→ 37,058 total
  • Award
    NovoCure Ltd$NVCR

    Restricted Share Units

    2020-03-03+19,220→ 89,252 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-02-28$72.22/sh−2,643→ 70,032 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Restricted Stock Units

    2020-02-27−5,556→ 5,555 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-02-27$79.45/sh+5,556→ 72,675 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-02-25$81.16/sh−8,482→ 67,119 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-02-24$88.26/sh+21,666→ 75,601 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Restricted Stock Units

    2020-02-24−21,666→ 0 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-01-08$52.58/sh+35→ 53,935 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-09-03$88.22/sh−24,083→ 65,800 total

Companies

1

Recent Filings

8

Address

C/O NOVOCURE INC. 20 VALLEY STREAM PKWY SUITE 300

MALVERN, PA, 19355

View on SEC.gov